X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. PFIZER FDC LTD./
PFIZER
 
P/E (TTM) x 28.9 31.4 92.0% View Chart
P/BV x 6.0 5.0 120.7% View Chart
Dividend Yield % 0.8 0.6 121.1%  

Financials

 FDC LTD.   PFIZER
EQUITY SHARE DATA
    FDC LTD.
Mar-14
PFIZER
Mar-16
FDC LTD./
PFIZER
5-Yr Chart
Click to enlarge
High Rs1442,724 5.3%   
Low Rs791,611 4.9%   
Sales per share (Unadj.) Rs47.6440.9 10.8%  
Earnings per share (Unadj.) Rs7.648.7 15.6%  
Cash flow per share (Unadj.) Rs9.075.8 11.9%  
Dividends per share (Unadj.) Rs2.2515.00 15.0%  
Dividend yield (eoy) %2.00.7 292.2%  
Book value per share (Unadj.) Rs47.5462.9 10.3%  
Shares outstanding (eoy) m177.8345.75 388.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.34.9 47.6%   
Avg P/E ratio x14.644.5 32.8%  
P/CF ratio (eoy) x12.328.6 43.2%  
Price / Book Value ratio x2.34.7 50.0%  
Dividend payout %29.630.8 96.0%   
Avg Mkt Cap Rs m19,78499,163 20.0%   
No. of employees `000NA2.9 0.0%   
Total wages/salary Rs m1,2212,758 44.3%   
Avg. sales/employee Rs ThNM6,981.7-  
Avg. wages/employee Rs ThNM954.5-  
Avg. net profit/employee Rs ThNM771.1-  
INCOME DATA
Net Sales Rs m8,45920,170 41.9%  
Other income Rs m394857 45.9%   
Total revenues Rs m8,85221,028 42.1%   
Gross profit Rs m2,0704,310 48.0%  
Depreciation Rs m2491,239 20.1%   
Interest Rs m315 596.3%   
Profit before tax Rs m2,1843,923 55.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m6061,794 33.7%   
Profit after tax Rs m1,3532,228 60.7%  
Gross profit margin %24.521.4 114.5%  
Effective tax rate %27.745.7 60.6%   
Net profit margin %16.011.0 144.8%  
BALANCE SHEET DATA
Current assets Rs m4,35516,299 26.7%   
Current liabilities Rs m1,7927,594 23.6%   
Net working cap to sales %30.343.2 70.2%  
Current ratio x2.42.1 113.2%  
Inventory Days Days4465 68.1%  
Debtors Days Days2526 95.8%  
Net fixed assets Rs m3,0258,622 35.1%   
Share capital Rs m179458 39.0%   
"Free" reserves Rs m8,24320,722 39.8%   
Net worth Rs m8,45321,180 39.9%   
Long term debt Rs m1125 42.8%   
Total assets Rs m10,55729,137 36.2%  
Interest coverage x71.4755.5 9.5%   
Debt to equity ratio x00 107.2%  
Sales to assets ratio x0.80.7 115.7%   
Return on assets %13.17.7 171.1%  
Return on equity %16.010.5 152.2%  
Return on capital %23.519.0 123.8%  
Exports to sales %13.30.1 22,369.6%   
Imports to sales %3.317.5 19.1%   
Exports (fob) Rs m1,12612 9,380.8%   
Imports (cif) Rs m2833,526 8.0%   
Fx inflow Rs m1,14652 2,219.0%   
Fx outflow Rs m355140 253.8%   
Net fx Rs m791-88 -895.3%   
CASH FLOW
From Operations Rs m1,4853,436 43.2%  
From Investments Rs m-620-6,991 8.9%  
From Financial Activity Rs m-753-619 121.6%  
Net Cashflow Rs m113-4,174 -2.7%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 4.7 7.5 62.7%  
FIIs % 7.5 4.9 153.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 23.7 80.2%  
Shareholders   23,730 85,207 27.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   GSK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  STERLING BIOTECH  JUBILANT LIFE SCIENCES  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 16, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS